Dr. George and Dr. Hurley discuss the data generated from their study on the correlation between deleterious variants in genes and the development of hereditary breast and ovarian cancers in populations throughout the Caribbean.
Back
Examining Actionable Pathogenic Variants in Caribbean Adults With Breast or Ovarian Cancers
Sophia George, PhD, and Judith E. Hurley, MD, walk through their study which found that 1 in 7 Caribbean-born adults with either breast or ovarian cancer had hereditary disease with an actionable pathogenic variant, providing opportunities for targeted therapies and unique preventative approaches.
Examining Actionable Pathogenic Variants in Caribbean Adults With Breast or Ovarian Cancers
Episodes
All
All
Current breast cancer screening practices in the Caribbean exclude the majority of the younger patient population, thereby leaving many cases of breast cancer undiagnosed.
Sophia George, PhD, discusses actionable pathogenic variants in patients with breast cancer who live in the Caribbean.
Judith E. Hurley, MD, discusses the baseline characteristics of patients with breast cancer in the Caribbean vs those in the United States.
One in 7 Caribbean-born individuals with either breast or ovarian cancer had hereditary disease with an actionable pathogenic variant, which provides the opportunity for the utilization of targeted therapeutics and precise prevention strategies.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
3
Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC
4
Etentamig Meets PFS, ORR Primary End Points in Triple-Class Exposed R/R Myeloma
5